Announced Sat, 26 Sept, 2026 · 11:50 IST
Trading Window Closed from Oct 1 Until Q2 FY27 Results Declaration
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹350.05
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+4.0+6.1+8.2+10.4+12.3+17.1————
Up moveDown movePending
AI summary
Bafna Pharmaceuticals has closed its trading window from October 1, 2026 until 48 hours after the company declares its unaudited financial results for the quarter ending September 30, 2026. During this period, designated persons and their immediate relatives cannot trade in company shares. This is a routine SEBI-mandated compliance under Insider Trading Regulations, typically done ahead of quarterly earnings announcement.
Likely market impact
Routine compliance notice. Insiders barred from trading until Q2 results are announced. No material impact on shareholders expected.